Nanjing Vazyme Biotech Co.,Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 301.57 million compared to CNY 302.19 million a year ago. Net income was CNY 5.22 million compared to net loss of CNY 50.62 million a year ago.

Basic earnings per share from continuing operations was CNY 0.01 compared to basic loss per share from continuing operations of CNY 0.13 a year ago. Diluted earnings per share from continuing operations was CNY 0.01 compared to diluted loss per share from continuing operations of CNY 0.13 a year ago.